Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Effector Therapeutics Inc
(NQ:
EFTR
)
0.1800
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.1800
Bid (Size)
0.1400 (3)
Ask (Size)
0.1550 (11)
Prev. Close
0.1800
Today's Range
0.1800 - 0.1800
52wk Range
0.1800 - 19.50
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Publicly Traded Companies Filing for Bankruptcy as July Kicks Off
July 15, 2024
Explore bankruptcy risk stocks with insights on Chicken Soup for the Soul Entertainment, eFFECTOR Therapeutics, and Delta Apparel.
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 26, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!
Via
InvestorPlace
Performance
YTD
-98.53%
-98.53%
1 Month
N/A
N/A
3 Month
-90.37%
-90.37%
6 Month
-98.36%
-98.36%
1 Year
-98.95%
-98.95%
More News
Read More
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
June 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why eFFECTOR Therapeutics (EFTR) Shares Are Down Over 70%
June 24, 2024
Via
Benzinga
eFFECTOR Therapeutics Announces it will Wind Down Operations as it Seeks Strategic Alternatives and Expects to be Delisted from Nasdaq
June 24, 2024
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 28, 2024
Via
Benzinga
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer
May 20, 2024
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
EFTR Stock Earnings: eFFECTOR Therapeutics Meets EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 09, 2024
Via
Benzinga
eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
eFFECTOR Therapeutics to Participate in Upcoming Investor Conference
April 09, 2024
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
April 05, 2024
Via
Benzinga
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
April 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 04, 2024
Via
Benzinga
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
April 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cancer-Focused eFFECTOR Therapeutics Shelves Development Of Lung Cancer Candidate After Disappointing Data
April 04, 2024
Via
Benzinga
Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000
April 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer
April 04, 2024
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 26, 2024
Via
InvestorPlace
EFTR Stock Earnings: eFFECTOR Therapeutics Misses EPS for Q4 2023
March 25, 2024
Via
InvestorPlace
eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 25, 2024
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
March 08, 2024
Via
Benzinga
eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 05, 2024
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
January 29, 2024
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.